References
1. Ko, JK, Auyeung, KK. Inflammatory bowel disease: etiology, pathogenesis and current therapy. Curr Pharm Des 2014; 20,1082-96.https://www.doi.org/10.2174/13816128113199990416
2. Greuter, T, Vavricka, SR. Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol 2019; 13,307-17.https://www.doi.org/10.1080/17474124.2019.1574569
3. Gajendran, M, Loganathan, P, Catinella, AP, Hashash, JG. A comprehensive review and update on Crohn’s disease. Dis Mon 2018; 64,20-57.https://www.doi.org/10.1016/j.disamonth.2017.07.001
4. Ordas, I, Eckmann, L, Talamini, M, Baumgart, DC, Sandborn, WJ. Ulcerative colitis. Lancet 2012; 380,1606-19.https://www.doi.org/10.1016/s0140-6736(12)60150-0
5. Fiocchi, C. Inflammatory bowel disease pathogenesis: where are we? J Gastroenterol Hepatol 2015; 30 Suppl 1,12-8.https://www.doi.org/10.1111/jgh.12751
6. Burisch, J, Jess, T, Martinato, M, Lakatos, PL. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013; 7,322-37.https://www.doi.org/10.1016/j.crohns.2013.01.010
7. Zundler, S, Neurath, MF. Immunopathogenesis of inflammatory bowel diseases: functional role of T cells and T cell homing. Clin Exp Rheumatol 2015; 33,S19-28.
8. Wallace, KL, Zheng, LB, Kanazawa, Y, Shih, DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol 2014; 20,6-21.https://www.doi.org/10.3748/wjg.v20.i1.6
9. Park, HK, Kwak, MK, Kim, HJ, Ahima, RS. Linking resistin, inflammation, and cardiometabolic diseases. Korean J Intern Med 2017; 32,239-47.https://www.doi.org/10.3904/kjim.2016.229
10. Jamaluddin, MS, Weakley, SM, Yao, Q, Chen, C. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 2012; 165,622-32.https://www.doi.org/10.1111/j.1476-5381.2011.01369.x
11. Jung, HS, Park, KH, Cho, YM, Chung, SS, Cho, HJ, Cho, SY, Kim, SJ, Kim, SY, Lee, HK, Park, KS. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 2006; 69,76-85.https://www.doi.org/10.1016/j.cardiores.2005.09.015
12. Karmiris, K, Koutroubakis, IE, Kouroumalis, EA. Leptin, adiponectin, resistin, and ghrelin–implications for inflammatory bowel disease. Mol Nutr Food Res 2008; 52,855-66.https://www.doi.org/10.1002/mnfr.200700050
13. Trejo-Vazquez, F, Garza-Veloz, I, Villela-Ramirez, GA, et al. Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control study. Exp Ther Med 2018; 15,3336-44.https://www.doi.org/10.3892/etm.2018.5835
14. Frivolt, K, Schwerd, T, Schatz, SB, Freudenberg, F, Prell, C, Werkstetter, KJ, Bufler, P, Koletzko, S. Hyperadiponectinemia During Infliximab Induction Therapy in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr 2018; 66,915-9.https://www.doi.org/10.1097/mpg.0000000000001876
15. Theocharidou, E, Balaska, A, Vogiatzis, K, Tellis, CC, Gossios, TD, Athyros, VG, Tselepis, AD, Karagiannis, A. Hypertrophic Mesenteric Adipose Tissue May Play a Role in Atherogenesis in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2016; 22,2206-12.https://www.doi.org/10.1097/mib.0000000000000873
16. Waluga, M, Hartleb, M, Boryczka, G, Kukla, M, Zwirska-Korczala, K. Serum adipokines in inflammatory bowel disease. World J Gastroenterol 2014; 20,6912-7.https://www.doi.org/10.3748/wjg.v20.i22.6912
17. Bostrom, EA, Ekstedt, M, Kechagias, S, Sjowall, C, Bokarewa, MI, Almer, S. Resistin is associated with breach of tolerance and anti-nuclear antibodies in patients with hepatobiliary inflammation. Scand J Immunol 2011; 74,463-70.https://www.doi.org/10.1111/j.1365-3083.2011.02592.x
18. Kader, NA, El-Din, FA, Khatab, EA, NE, EL. Does plasma resistin level have a role in predicting inflammatory bowel disease activity? Indian J Gastroenterol 2010; 29,126-7.
19. Konrad, A, Lehrke, M, Schachinger, V, Seibold, F, Stark, R, Ochsenkuhn, T, Parhofer, KG, Goke, B, Broedl, UC. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol 2007; 19,1070-4.https://www.doi.org/10.1097/MEG.0b013e3282f16251
20. Karmiris, K, Koutroubakis, IE, Xidakis, C, Polychronaki, M, Voudouri, T, Kouroumalis, EA. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12,100-5.https://www.doi.org/10.1097/01.mib.0000200345.38837.46
21. Abedimanesh, N, Motlagh, B, Abedimanesh, S, Ostadrahimi, A, Somi, MH, Jafarabad, MA, Rezazadeb, M. Circulating resistin in ulcerative colitis, relation with anthropometric, body composition and inflammatory parameters. Progress in Nutrition 2018; 20,132-6.https://www.doi.org/10.23751/pn.v20i2-S.6560
22. Tan, K. The relationship between serum Levels of Resistin, YKL-40 and uIcerative colitis. University of south China 2012.
23. Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, Moher, D, Becker, BJ, Sipe, TA, Thacker, SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 2000; 283,2008-12.https://www.doi.org/10.1001/jama.283.15.2008
24. Hozo, SP, Djulbegovic, B, Hozo, I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5,13.https://www.doi.org/10.1186/1471-2288-5-13
25. Silswal, N, Singh, AK, Aruna, B, Mukhopadhyay, S, Ghosh, S, Ehtesham, NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005; 334,1092-101.https://www.doi.org/10.1016/j.bbrc.2005.06.202
26. Kyriakou, A, Patsatsi, A, Sotiriadis, D, Goulis, DG. Serum Leptin, Resistin, and Adiponectin Concentrations in Psoriasis: A Meta-Analysis of Observational Studies. Dermatology 2017; 233,378-89.https://www.doi.org/10.1159/000481882
27. Yang, J, Zhang, X, Ma, Y, et al. Serum levels of leptin, adiponectin and resistin in patients with ankylosing spondylitis: A systematic review and meta-analysis. Int Immunopharmacol 2017; 52,310-7.https://www.doi.org/10.1016/j.intimp.2017.09.029
28. Huang, Q, Tao, SS, Zhang, YJ, et al. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Clin Rheumatol 2015; 34,1713-20.https://www.doi.org/10.1007/s10067-015-2955-5
29. Hutcheson, J. Adipokines influence the inflammatory balance in autoimmunity. Cytokine 2015; 75,272-9.https://www.doi.org/10.1016/j.cyto.2015.04.004
30. Tsiotra, PC, Boutati, E, Dimitriadis, G, Raptis, SA. High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. Biomed Res Int 2013; 2013,487081.https://www.doi.org/10.1155/2013/487081
31. Acquarone, E, Monacelli, F, Borghi, R, Nencioni, A, Odetti, P. Resistin: A reappraisal. Mech Ageing Dev 2019; 178,46-63.https://www.doi.org/10.1016/j.mad.2019.01.004
32. Torres, J, Mehandru, S, Colombel, JF, Peyrin-Biroulet, L. Crohn’s disease. Lancet 2017; 389,1741-55.https://www.doi.org/10.1016/s0140-6736(16)31711-1
33. Adams, SM, Bornemann, PH. Ulcerative colitis. Am Fam Physician 2013; 87,699-705.
34. Schaffler, A, Scholmerich, J, Buchler, C. Mechanisms of disease: adipocytokines and visceral adipose tissue–emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2005; 2,103-11.https://www.doi.org/10.1038/ncpgasthep0090
35. Kreuter, R, Wankell, M, Ahlenstiel, G, Hebbard, L. The role of obesity in inflammatory bowel disease. Biochim Biophys Acta Mol Basis Dis 2019; 1865,63-72.https://www.doi.org/10.1016/j.bbadis.2018.10.020